scholarly journals CORRECTION OF THROMBOCYTOPOIESIS IN RATS WITH WALKER-256 CARCINOMA USING AN ANTIOXIDANT SUPPLEMENT IN THE SETTING OF CYTOSTATICS

2021 ◽  
Vol 11 (3) ◽  
pp. 14-16
Author(s):  
Alexander Siprov ◽  
Mariya Solovyova ◽  
Pavel Skopin ◽  
Larisa Mosina ◽  
Yulia Skopina ◽  
...  

— In this study, we’ve evaluated the myelotoxic effect of treating Walker-256 carcinoma with cytostatics, followed by correction of thrombocytopenia with liposomal and liposome-free mexidol. The study included 60 rats, which, depending on the type of treatment, were divided into 5 groups. We recorded the greatest increase in the number of platelets on the background of liposomal mexidol both on the 3rd and 7th day after the start of chemotherapy. At the end of the monitoring, the myeloprotective effect was 30% higher in the liposomal mexidol compared to its non-liposomal form. Conclusion: Activation of thrombocytopoiesis on the background of cytostatic therapy helps to reduce the complications related to the use of chemotherapy.

Author(s):  
Balykova L.A. ◽  
Siprov A.V. ◽  
Inchina V.I. ◽  
Tarasova T.V. ◽  
Mosina L.M. ◽  
...  

Among malignant neoplasms of women, breast cancer (BC) takes the leading place and is the cause of high mortality and complications. Side effects in the form of anemia, thrombocytopenia, bleeding, etc. often develop during cytostatic therapy, which is the main method of treatment and prevention of further development of the oncological process. In this regard, the problem of reducing side metabolic disorders remains relevant and creates a search field for the use of drugs aimed at stabilizing functions, both at the cellular and organ levels. The aim of the study was to evaluate the effect of cytostatic drugs on thrombocytopoiesis in rats with WALKER-256 carcinoma. The study included 60 rats, which, depending on the type of treatment, were divided into 5 groups. A week after the start of chemotherapy, the greatest increase in the number of platelets was in the presence of liposomal ethylmethylhydroxypyridine succinate. We recorded that the myeloprotective effect was 1/3 better in liposomal ethylmethylhydroxypyridine succinate compared to its non-liposomal form. Therefore, individuals those receiving cytostatic drugs in the treatment of breast cancer need protection from myelopoiesis. In the studies carried out by us, it was shown that oxidative stress occurred in animals against the background of treatment with cytostatics. It was its rapid development that caused damage to the platelet cell membranes. In this regard, we have proposed a drug with a pronounced antioxidant efficacy. The introduction of an antioxidant into the generally accepted standard treatment of a tumor process has made it possible to experimentally select methods for delivering the drug to the targets of damage using liposomal forms. The study obtained data proving the effectiveness of the use of liposomal ethylmethylhydroxypyridine succinate (50 mg / kg), in contrast to its free form, which prevents the development of thrombocytopenia induced by the administration of cytostatic drugs to rats with Walker-256 carcinoma.


2021 ◽  
Vol 8 (4) ◽  
pp. 23-32
Author(s):  
L. A. Balykova ◽  
V. I. Inchina ◽  
T. V. Tarasova ◽  
L. M. Mosina ◽  
E. N. Gvozdikova ◽  
...  

Purpose of the study. To evaluate the antitumor efficacy of liposomal doxorubicin hydrochloride in combination with tamoxifen in the treatment of breast cancer.Materials and methods. The study included mongrel white rats (n = 30). A model of carcinogenesis (Walker 256 tumors) was created for all animals. Then we divided these rats into 3 equal groups: 1 control group (n = 10) - animals were monitored without treatment; 2 group (n = 10) - animals received neoadjuvant therapy: liposomal doxorubicin hydrochloride + cyclophosphan; 3 group (n = 10) - animals received neoadjuvant therapy with doxorubicin hydrochloride (non-liposomal) and cyclophosphan. Animals of the second and third groups received two cycles of neoadjuvant therapy. All animals were monitored for 1.5 months. We evaluated the effectiveness of antitumor therapy by measuring the size of tumors, the dynamics of their regression, and counting the number of metastases in the lungs. The toxic effects of doxorubicin hydrochloride were assessed by blood parameters: platelet and lymphocyte levels.Results. We recorded a significant inhibition of the growth of tumor nodes in the second group of rats on the 25th day from the start of the experiment compared with the first and third groups: 36004.7, 86112.1 and 38962.4 mm3, respectively. By the end of the 3rd week of the experiment, we also noted the formation of a tumor regression trend in the 2nd and 3rd groups of animals, which was reliably maintained until the end of the observation. At the end of the experiment, the number of metastases in the first group of animals was 3 times more, in the third group almost 1.5 times more than in the second (p < 0.05)Conclusion. The treatment of Walker 256 tumor with liposomal doxorubicin showed better efficacy and safety in comparison with non-liposomal doxorubicin. The tumor volume becomes smaller against the background of neoadjuvant chemotherapy with liposomal doxorubicin hydrochloride compared with its non-liposomal form, while there is no pronounced decrease in platelets and lymphocytes. We also recorded a significantly lower number of lung metastases in animals of the second group compared to other groups.


Author(s):  
Александр Владимирович Сипров ◽  
Владимир Андреевич Масягин ◽  
Евгений Владимирович Тютяев ◽  
Илья Владимирович Сюсин
Keyword(s):  

Изучено влияние ксимедона (100 мг/кг однократно ежедневно 10 дней внутримышечно, начиная с 11 сут после имплантации опухолевых клеток) в сравнении с мексидолом (50 мг/кг однократно ежедневно 10 дней внутримышечно с 11 сут после имплантации опухолевых клеток) на морфометрические показатели эритроцитов и кислородтранспортную функцию гемоглобина у крыс с карциномой Walker-256 на фоне доксорубицина. Показано, что ксимедон сопоставимо с мексидолом предупреждает изменения геометрии эритроцитов, ассоциированные с использованием доксорубицина (уменьшение площади и объема эритроцитов) и опухолевой прогрессией (уменьшение объема эритроцитов), восстанавливая площадь и объем эритроцитов на 21 и 22 %, соответственно на 14 сут после введения опухолевых клеток. Ксимедон эффективнее мексидола оптимизирует кислородтранспортную функцию гемоглобина в ранние сроки после введения доксорубицина (14 сут эксперимента), увеличивая на 9 % и нормализуя таким образом способность гемоглобина отдавать кислород (на 7 % больше в сравнении с мексидолом, p < 0,05) при умеренном росте на 17 % сродства гемоглобина к кислороду (на 28 % меньше относительно мексидола, p < 0,05). В поздние сроки исследования (22 сут) ксимедон уступает мексидолу в коррекции кислородтранспортной функции гемоглобина (способность гемоглобина связывать и отдавать кислород снижается на 13 и 6 %, соответственно, относительно монотерапии доксорубицином, и на 22 и 6,5 % в сравнении с мексидолом, p < 0,05).


Author(s):  
Александр Николаевич Стуков ◽  
Кирилл Александрович Есиков ◽  
Лилия Маратовна Усманова ◽  
Наталья Николаевна Харитонова ◽  
София Фатхутдиновна Вершинина ◽  
...  
Keyword(s):  

Взаимодействием 2-хлорэтилизоцианата с 2-амино-1,3-пропандиолом в смеси ацетонитрил — метанол получают 2-[3-(2-хлорэтил)уреидо]-1,3-пропандиол, который нитрозируют в 50 % растворе муравьиной кислоты с помощью нитрита натрия, получая 2-[3-(2-хлорэтил)-3-нитрозоуреидо]-1,3-пропандиол (хлонизол). При однократном введении в нетоксичной дозе 15 мг/кг хлонизол увеличивал медиану продолжительности жизни мышей с лейкемией Р-388 на 170 % и вызывал излечение 100 % крыс с карциносаркомой Walker 256.


2017 ◽  
Vol 9 (2) ◽  
pp. 171-175
Author(s):  
O Shtapenko ◽  
◽  
I Gevkan ◽  
Yu Slyvchyk ◽  
V Syrvatka ◽  
...  
Keyword(s):  

Metabolites ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 404
Author(s):  
Gabriela de Matuoka e Chiocchetti ◽  
Leisa Lopes-Aguiar ◽  
Natália Angelo da Silva Miyaguti ◽  
Lais Rosa Viana ◽  
Carla de Moraes Salgado ◽  
...  

Cancer cachexia is a severe wasting condition that needs further study to find ways to minimise the effects of damage and poor prognosis. Skeletal muscle is the most impacted tissue in cancer cachexia; thus, elucidation of its metabolic alterations could provide a direct clue for biomarker research and be applied to detect this syndrome earlier. In addition, concerning the significant changes in the host metabolism across life, this study aimed to compare the metabolic muscle changes in cachectic tumour-bearing hosts at different ages. We performed 1H-NMR metabolomics in the gastrocnemius muscle in weanling and young adult Walker-256 tumour-bearing rats at different stages of tumour evolution (initial, intermediate, and advanced). Among the 49 metabolites identified, 24 were significantly affected throughout tumour evolution and 21 were significantly affected regarding animal age. The altered metabolites were mainly related to increased amino acid levels and changed energetic metabolism in the skeletal muscle, suggesting an expressive catabolic process and diverted energy production, especially in advanced tumour stages in both groups. Moreover, these changes were more severe in weanling hosts throughout tumour evolution, suggesting the distinct impact of cancer cachexia regarding the host’s age, highlighting the need to adopting the right animal age when studying cancer cachexia.


2009 ◽  
Vol 46 (3) ◽  
pp. 430-440 ◽  
Author(s):  
Kalpana Velmurugan ◽  
Jawed Alam ◽  
Joe M. McCord ◽  
Subbiah Pugazhenthi

1970 ◽  
Vol 40 (5) ◽  
pp. 1201-1208 ◽  
Author(s):  
N. Raghuveer Ballal ◽  
Michael S. Collins ◽  
Richard M. Halpern ◽  
Roberts A. Smith

1997 ◽  
Vol 17 (11) ◽  
pp. 1239-1253 ◽  
Author(s):  
Hisao Uehara ◽  
Tadashi Miyagawa ◽  
Juri Tjuvajev ◽  
Revathi Joshi ◽  
Bradley Beattie ◽  
...  

The goal of this study was to evaluate the differences and define the advantages of imaging experimental brain tumors in rats with two nonmetabolized amino acids, 1-aminocyclopentane carboxylic (ACPC) acid and α-aminoisobutyric (AIB) acid compared with imaging with fluorodeoxyglucose (FDG) or the gallium-diethylenetriaminepentaacetic acid chelate (Ga-DTPA). 1-aminocyclopentane carboxylic acid, AIB, and FDG autoradiograms were obtained 60 minutes after intravenous injection to simulate positron emission tomography (PET) imaging, whereas the Ga-DTPA autoradiograms were obtained 5 or 10 minutes after injection to simulate gadolinium (Gd)-DTPA–enhanced magnetic resonance (MR) images. Three experimental tumors were studied (C6, RG2, and Walker 256) to provide a range of tumor types. Triple-label quantitative autoradiography was performed, and parametric images of the apparent distribution volume (Va, mL/g) for ACPC or AIB, relative glucose metabolism (R, μmol/100 g/min), vascular permeability to Ga-DTPA (K1, μL/min/g), and histology were obtained from the same tissue section. The four images were registered in an image array processor, and regions of interest in tumor and contralateral brain were defined on morphologic criteria (histology) and were transferred to the autoradiographic images. A comparative analysis of all measured values was performed. The location and morphologic characteristics of the tumor had an effect on the images and measurements of Va, R, and K1. Meningeal extensions of all three tumors consistently had the highest amino acid uptake (Va) and vascular permeability (K1) values, and subcortical portions of the tumors usually had the lowest values. Va and R (FDG) values generally were higher in tumor regions with high-cell density and lower in regions with low-cell density. Tumor areas identified as “impending” necrosis on morphologic criteria consistently had high R values, but little or no change in Va or K1. Tumor necrosis was seen consistently only in the larger Walker 256 tumors; low values of R and Va for AIB (less for ACPC) were measured in the necrotic-appearing regions, whereas K1 was not different from the mean tumor value. The highest correlations were observed between vascular permeability (K1 for Ga-DTPA) and Va for AIB in all three tumors; little or no correlation between vascular permeability and R was observed. The advantages of ACPC and AIB imaging were most convincingly demonstrated in C6 gliomas and in Walker 256 tumors. 1-aminocyclopentane was substantially better than FDG or Ga-DTPA for identifying tumor infiltration of adjacent brain tissue beyond the macroscopic border of the tumor; ACPC also may be useful for identifying low-grade tumors with an intact blood–brain barrier. Contrast-enhancing regions of the tumors were visualized more clearly with AIB than with FDG or Ga-DTPA; viable and necrotic-appearing tumor regions could be distinguished more readily with AIB than with FDG. [11C]-labeled ACPC and AIB are likely to have similar advantages for imaging human brain tumors with PET.


Sign in / Sign up

Export Citation Format

Share Document